These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
559 related articles for article (PubMed ID: 20130052)
1. A mouse model of lethal infection for evaluating prophylactics and therapeutics against Monkeypox virus. Stabenow J; Buller RM; Schriewer J; West C; Sagartz JE; Parker S J Virol; 2010 Apr; 84(8):3909-20. PubMed ID: 20130052 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model. Hutson CL; Kondas AV; Mauldin MR; Doty JB; Grossi IM; Morgan CN; Ostergaard SD; Hughes CM; Nakazawa Y; Kling C; Martin BE; Ellison JA; Carroll DS; Gallardo-Romero NF; Olson VA mSphere; 2021 Feb; 6(1):. PubMed ID: 33536322 [TBL] [Abstract][Full Text] [Related]
3. Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection. Stittelaar KJ; Neyts J; Naesens L; van Amerongen G; van Lavieren RF; Holý A; De Clercq E; Niesters HG; Fries E; Maas C; Mulder PG; van der Zeijst BA; Osterhaus AD Nature; 2006 Feb; 439(7077):745-8. PubMed ID: 16341204 [TBL] [Abstract][Full Text] [Related]
4. Experimental infection of an African dormouse (Graphiurus kelleni) with monkeypox virus. Schultz DA; Sagartz JE; Huso DL; Buller RM Virology; 2009 Jan; 383(1):86-92. PubMed ID: 18977501 [TBL] [Abstract][Full Text] [Related]
5. Identification of wild-derived inbred mouse strains highly susceptible to monkeypox virus infection for use as small animal models. Americo JL; Moss B; Earl PL J Virol; 2010 Aug; 84(16):8172-80. PubMed ID: 20519404 [TBL] [Abstract][Full Text] [Related]
6. Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge. Russo AT; Berhanu A; Bigger CB; Prigge J; Silvera PM; Grosenbach DW; Hruby D Vaccine; 2020 Jan; 38(3):644-654. PubMed ID: 31677948 [TBL] [Abstract][Full Text] [Related]
7. Treatment and Vaccination for Smallpox and Monkeypox. Saalbach KP Adv Exp Med Biol; 2024; 1451():301-316. PubMed ID: 38801586 [TBL] [Abstract][Full Text] [Related]
8. Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus. Stittelaar KJ; van Amerongen G; Kondova I; Kuiken T; van Lavieren RF; Pistoor FH; Niesters HG; van Doornum G; van der Zeijst BA; Mateo L; Chaplin PJ; Osterhaus AD J Virol; 2005 Jun; 79(12):7845-51. PubMed ID: 15919938 [TBL] [Abstract][Full Text] [Related]
9. Lethal monkeypox virus infection of CAST/EiJ mice is associated with a deficient gamma interferon response. Earl PL; Americo JL; Moss B J Virol; 2012 Sep; 86(17):9105-12. PubMed ID: 22696658 [TBL] [Abstract][Full Text] [Related]
10. Treatment with the smallpox antiviral tecovirimat (ST-246) alone or in combination with ACAM2000 vaccination is effective as a postsymptomatic therapy for monkeypox virus infection. Berhanu A; Prigge JT; Silvera PM; Honeychurch KM; Hruby DE; Grosenbach DW Antimicrob Agents Chemother; 2015 Jul; 59(7):4296-300. PubMed ID: 25896687 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of disease and viral biomarkers as triggers for therapeutic intervention in respiratory mousepox - an animal model of smallpox. Parker S; Chen NG; Foster S; Hartzler H; Hembrador E; Hruby D; Jordan R; Lanier R; Painter G; Painter W; Sagartz JE; Schriewer J; Mark Buller R Antiviral Res; 2012 Apr; 94(1):44-53. PubMed ID: 22381921 [TBL] [Abstract][Full Text] [Related]